Cargando…
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
BACKGROUND: Post-surgical prognosis is usually poor for combined hepatocellular cholangiocarcinoma (CHCC-CC), a rare primary liver cancer. Although midkine (MK) is a prognostic biomarker for several known cancers, it is not known whether it can be used as such in resectable CHCC-CC. This study exami...
Autores principales: | Ma, Ming-Chun, Chen, Yi-Ju, Chiu, Tai-Jan, Lan, Jui, Liu, Chien-Ting, Chen, Yi-Ching, Tien, Hsin-Ho, Chen, Yen-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830052/ https://www.ncbi.nlm.nih.gov/pubmed/29486735 http://dx.doi.org/10.1186/s12885-018-4146-7 |
Ejemplares similares
-
Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma
por: Chiu, Tai-Jan, et al.
Publicado: (2023) -
Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma
por: Chiu, Tai-Jan, et al.
Publicado: (2020) -
Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019) -
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019) -
Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)